CGEM

Cullinan Therapeutics Inc

NASDAQ · Biotechnology

$12.23

+0.38 (+3.21%)

Small-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

17 analysts

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +75.4% upside

Low Target $16.94

Average Target $21.45

High Target $32.37

Current Price $12.23

Current
$12.23

Target
$21.45

$16.94 $21.45 avg $32.37